129 related articles for article (PubMed ID: 38621197)
1. Utilization and Outcomes of Multigene Panel Testing in Patients With Pancreatic Ductal Adenocarcinoma.
Klatte DCF; Starr JS; Clift KE; Hardway HD; van Hooft JE; van Leerdam ME; Potjer TP; Presutti RJ; Riegert-Johnson DL; Wallace MB; Bi Y
JCO Oncol Pract; 2024 Apr; ():OP2300447. PubMed ID: 38621197
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Universal Point-of-Care Genetic Testing in Diverse Patients With Pancreatic Ductal Adenocarcinoma.
Drogan CM; Kindler HL; Gao G; Kupfer SS
JCO Precis Oncol; 2023 Jan; 7():e2200196. PubMed ID: 36689696
[TBL] [Abstract][Full Text] [Related]
3. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
4. Implications of Multigene Panel Testing on Psychosocial Outcomes: A Comparison of Patients With Pancreatic and Breast or Ovarian Cancer.
Koptiuch C; Espinel WF; Kohlmann WK; Zhao J; Kaphingst KA
JCO Precis Oncol; 2021; 5():. PubMed ID: 34250392
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Anaphylaxis Management in a Pediatric Emergency Department.
Sidhu N; Jones S; Perry T; Thompson T; Storm E; Melguizo Castro MS; Nick TG
Pediatr Emerg Care; 2016 Aug; 32(8):508-13. PubMed ID: 27490724
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Germline Pathogenic Variants in Cancer Predisposing Genes in Czech and Belgian Pancreatic Cancer Patients.
Wieme G; Kral J; Rosseel T; Zemankova P; Parton B; Vocka M; Van Heetvelde M; Kleiblova P; Blaumeiser B; Soukupova J; van den Ende J; Nehasil P; Tejpar S; Borecka M; Gómez García EB; Blok MJ; Safarikova M; Kalousova M; Geboes K; De Putter R; Poppe B; De Leeneer K; Kleibl Z; Janatova M; Claes KBM
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503238
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Ductal Carcinoma Risk Associated With Hereditary Cancer-Risk Genes.
Gardiner A; Kidd J; Elias MC; Young K; Mabey B; Taherian N; Cummings S; Malafa M; Rosenthal E; Permuth JB
J Natl Cancer Inst; 2022 Jul; 114(7):996-1002. PubMed ID: 35445726
[TBL] [Abstract][Full Text] [Related]
8. Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer.
Chittenden A; Haraldsdottir S; Ukaegbu C; Underhill-Blazey M; Gaonkar S; Uno H; Brais LK; Perez K; Wolpin BM; Syngal S; Yurgelun MB
JCO Oncol Pract; 2021 Feb; 17(2):e236-e247. PubMed ID: 33439686
[TBL] [Abstract][Full Text] [Related]
9. The role of family history in predicting germline pathogenic variant carriers who develop pancreatic cancer: Results of a multicenter collaboration.
Karloski E; Dudley B; Diergaarde B; Blanco A; Everett JN; Levinson E; Rangarajan T; Stanich PP; Childers K; Brown S; Drogan C; Cavestro GM; Gordon K; Singh A; Simeone DM; Reich H; Kastrinos F; Zakalik D; Hampel H; Pearlman R; Gordon OK; Kupfer SS; Puzzono M; Zuppardo RA; Brand RE
Cancer; 2024 May; ():. PubMed ID: 38809542
[TBL] [Abstract][Full Text] [Related]
10. Patterns in Nonopioid Pain Medication Prescribing After the Release of the 2016 Guideline for Prescribing Opioids for Chronic Pain.
Goldstick JE; Guy GP; Losby JL; Baldwin GT; Myers MG; Bohnert ASB
JAMA Netw Open; 2022 Jun; 5(6):e2216475. PubMed ID: 35687334
[TBL] [Abstract][Full Text] [Related]
11. Hereditary Cancer Clinics Improve Adherence to NCCN Germline Testing Guidelines for Pancreatic Cancer.
Rosso C; Marciano ND; Nathan D; Chen WP; McLaren CE; Osann KE; Flodman PL; Cho MT; Lee FC; Dayyani F; Zell JA; Valerin JB
J Natl Compr Canc Netw; 2024 Jun; ():1-7. PubMed ID: 38889755
[TBL] [Abstract][Full Text] [Related]
12. Impact of comprehensive family history and genetic analysis in the multidisciplinary pancreatic tumor clinic setting.
Everett JN; Dettwyler SA; Jing X; Stender C; Schmitter M; Baptiste A; Chun J; Kawaler EA; Khanna LG; Gross SA; Gonda TA; Beri N; Oberstein PE; Simeone DM
Cancer Med; 2023 Feb; 12(3):2345-2355. PubMed ID: 35906821
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma.
Ryu KH; Park S; Chun JW; Cho E; Choi J; Lee DE; Shim H; Kim YH; Han SS; Park SJ; Woo SM; Kong SY
Cancer Res Treat; 2023 Oct; 55(4):1303-1312. PubMed ID: 37024097
[TBL] [Abstract][Full Text] [Related]
14. Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants.
Murali K; Dwarte TM; Nikfarjam M; Tucker KM; Vaughan RB; Efthymiou M; Collins A; Spigelman AD; Salmon L; Johns AL; Williams DB; Delatycki MB; John T; Stoita A
Hered Cancer Clin Pract; 2021 Aug; 19(1):33. PubMed ID: 34399810
[TBL] [Abstract][Full Text] [Related]
15. EUS-based Pancreatic Cancer Surveillance in
Katona BW; Long JM; Ahmad NA; Attalla S; Bradbury AR; Carpenter EL; Clark DF; Constantino G; Das KK; Domchek SM; Dudzik C; Ebrahimzadeh J; Ginsberg GG; Heiman J; Kochman ML; Maxwell KN; McKenna DB; Powers J; Shah PD; Wangensteen KJ; Rustgi AK
Cancer Prev Res (Phila); 2021 Nov; 14(11):1033-1040. PubMed ID: 34341011
[TBL] [Abstract][Full Text] [Related]
16. Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Brand R; Borazanci E; Speare V; Dudley B; Karloski E; Peters MLB; Stobie L; Bahary N; Zeh H; Zureikat A; Hogg M; Lee K; Tsung A; Rhee J; Ohr J; Sun W; Lee J; Moser AJ; DeLeonardis K; Krejdovsky J; Dalton E; LaDuca H; Dolinsky J; Colvin A; Lim C; Black MH; Tung N
Cancer; 2018 Sep; 124(17):3520-3527. PubMed ID: 30067863
[TBL] [Abstract][Full Text] [Related]
17. An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review.
Rainone M; Singh I; Salo-Mullen EE; Stadler ZK; O'Reilly EM
JAMA Oncol; 2020 May; 6(5):764-771. PubMed ID: 32053139
[TBL] [Abstract][Full Text] [Related]
18. Implementing the AAOS Guidelines for Screening of Developmental Dysplasia of the Hip Before the Age of 6 Months in Taiwan.
Hsu KH; Chang WC; Feng CK; Su YP
J Pediatr Orthop; 2023 Jul; 43(6):e416-e420. PubMed ID: 37043437
[TBL] [Abstract][Full Text] [Related]
19. The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.
Mohindroo C; De Jesus-Acosta A; Yurgelun MB; Maitra A; Mork M; McAllister F
Surg Pathol Clin; 2022 Sep; 15(3):491-502. PubMed ID: 36049831
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of retesting in patients with previously uninformative cancer genetics evaluations.
Dettwyler SA; Koeppe ES; Jacobs MF; Stoffel EM
Fam Cancer; 2022 Jul; 21(3):375-385. PubMed ID: 34545504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
